Stock RCKT ROCKET PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Rocket Pharmaceuticals, Inc.

Equities

RCKT

US77313F1066

Market Closed - Nasdaq
Other stock markets
 03:59:48 2024-06-04 pm EDT 		5-day change 1st Jan Change
22.21 USD +1.28% Intraday chart for Rocket Pharmaceuticals, Inc. +6.06% -25.89%
May. 29 Rocket Pharmaceuticals' Gene Therapy for Inherited Heart Disease Receives Orphan Drug Designation in Europe MT
May. 16 Transcript : Rocket Pharmaceuticals, Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 10:00 AM
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
ROCKET PHARMACEUTICALS, INC.
Bio Therapeutic Drugs
+1.28%+6.06%-25.89%+1.69%+39.77% 2.02B
Bearish
Bearish
Bullish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. RCKT Stock
  4. Charts Rocket Pharmaceuticals, Inc.
  5. Comparison Chart